P2X7R-NEK7-NLRP3 Inflammasome Activation: A Novel Therapeutic Pathway of Qishen Granule in the Treatment of Acute Myocardial Ischemia

References

• Bigler MR, Zimmermann P, Papadis A, et al. Accuracy of intracoronary ECG parameters for myocardial ischemia detection. J Electrocardiol. 2021;64:50–57. doi:10.1016/j.jelectrocard.2020.11.018
   PubMed Web of Science ®Google Scholar
• Barstow C. Acute coronary syndrome: presentation and diagnostic evaluation. FP Essent. 2020;490:11–19.
   PubMedGoogle Scholar
• Kapur NK, Qiao X, Paruchuri V, et al. Mechanical pre-conditioning with acute circulatory support before reperfusion limits infarct size in acute myocardial infarction. JACC Heart Fail. 2015;3:873–882. doi:10.1016/j.jchf.2015.06.010
   PubMed Web of Science ®Google Scholar
• Gong T, Liu L, Jiang W, et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20(2):95–112. doi:10.1038/s41577-019-0215-7
   PubMed Web of Science ®Google Scholar
• Green DR. The coming decade of cell death research: five riddles. Cell. 2019;177(5):1094–1107. doi:10.1016/j.cell.2019.04.024
   PubMed Web of Science ®Google Scholar
• Hua J, Liu Z, Liu Z, et al. Metformin increases cardiac rupture after myocardial infarction via the AMPK-MTOR/PGC-1α signaling pathway in rats with acute myocardial infarction. Med Sci Monit. 2018;24:6989–7000. doi:10.12659/MSM.910930
   PubMed Web of Science ®Google Scholar
• Fei Q, Ma H, Zou J, et al. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J Mol Cell Cardiol. 2020;145:1–13. doi:10.1016/j.yjmcc.2020.05.016
   PubMed Web of Science ®Google Scholar
• Huang L, Xiang M, Ye P, et al. Beta-catenin promotes macrophage-mediated acute inflammatory response after myocardial infarction. Immunol Cell Biol. 2018;96(1):100–113. doi:10.1111/imcb.1019
   PubMed Web of Science ®Google Scholar
• Fang L, Moore XL, Dart AM, et al. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12(3):305–312. doi:10.11909/j.issn.1671-5411.2015.03.020
   PubMedGoogle Scholar
• Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221–225. doi:10.1038/nature09663
   PubMed Web of Science ®Google Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5. doi:10.1189/jlb.0306164
   PubMed Web of Science ®Google Scholar
• Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018;15:203–214. doi:10.1038/nrcardio.2017.161
   PubMed Web of Science ®Google Scholar
• Toldo S, Mauro AG, Cutter Z, et al. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol. 2018;315:H1553–H1568. doi:10.1152/ajpheart.00158.2018
   PubMed Web of Science ®Google Scholar
• He Y, Zeng MY, Yang D, et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354–357. doi:10.1038/nature16959
   PubMed Web of Science ®Google Scholar
• Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21. doi:10.1111/imr.12296
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.
   PubMed Web of Science ®Google Scholar
• Du Y, Gu X, Meng H, et al. Muscone improves cardiac function in mice after myocardial infarction by alleviating cardiac macrophage-mediated chronic inflammation through inhibition of NF-κB and NLRP3 inflammasome. Am J Transl Res. 2018;10:4235–4246.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mezzaroma E, Mauro AG, et al. The inflammasome in myocardial injury and cardiac remodeling. Antioxid Redox Signal. 2015;22(13):1146–1161. doi:10.1089/ars.2014.5989
   PubMed Web of Science ®Google Scholar
• Gao S, Zhang Q, Tian C, et al. The roles of Qishen granules recipes, Qingre Jiedu, Wenyang Yiqi and Huo Xue, in the treatment of heart failure. J Ethnopharmacol. 2020;249:112372. doi:10.1016/j.jep.2019.112372
   PubMed Web of Science ®Google Scholar
• Chen X, Li Y, Li J, et al. Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats. J Ethnopharmacol. 2022;285:114841. doi:10.1016/j.jep.2021.114841
   PubMed Web of Science ®Google Scholar
• Lu W, Wang Q, Sun X, et al. Qishen granule improved cardiac remodeling via balancing M1 and M2 macrophages. Front Pharmacol. 2019;10:1399. doi:10.3389/fphar.2019.01399
   PubMed Web of Science ®Google Scholar
• Wang X, Li W, Zhang Y, et al. Calycosin as a novel PI3K activator reduces inflammation and fibrosis in heart failure through AKT-IKK/STAT3 axis. Front Pharmacol. 2022;13:828061. doi:10.3389/fphar.2022.828061
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Chen X, et al. Qishen granule (QSG) inhibits monocytes released from the spleen and protect myocardial function via the TLR4-MyD88-NF-κB p65 pathway in heart failure mice. Front Pharmacol. 2022;13:850187. doi:10.3389/fphar.2022.850187
   PubMed Web of Science ®Google Scholar
• Rauf A, Shah M, Yellon DM, et al. Role of caspase 1 in ischemia/reperfusion injury of the myocardium. J Cardiovasc Pharmacol. 2019;74(3):194–200. doi:10.1097/FJC.0000000000000694
   PubMed Web of Science ®Google Scholar
• Ren Z, Yang K, Zhao M, et al. Calcium-sensing receptor on neutrophil promotes myocardial apoptosis and fibrosis after acute myocardial infarction via NLRP3 inflammasome activation. Can J Cardiol. 2020;36:893–905. doi:10.1016/j.cjca.2019.09.026
   PubMed Web of Science ®Google Scholar
• Takahashi M. Cell-specific roles of NLRP3 inflammasome in myocardial infarction. J Cardiovasc Pharmacol. 2019;74:188–193. doi:10.1097/FJC.0000000000000709
   PubMed Web of Science ®Google Scholar
• Hwang MW, Matsumori A, Furukawa Y, et al. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol. 2001;38:1546–1553. doi:10.1016/S0735-1097(01)01591-1
   PubMed Web of Science ®Google Scholar
• Takahashi M. Role of NLRP3 inflammasome in cardiac inflammation and remodeling after myocardial infarction. Biol Pharm Bull. 2019;42:518–523. doi:10.1248/bpb.b18-00369
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang H, Kouadir M, et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128. doi:10.1038/s41419-019-1413-8
   PubMed Web of Science ®Google Scholar
• Woldbaek PR, Tønnessen T, Henriksen UL, et al. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res. 2003;59:122–131. doi:10.1016/S0008-6363(03)00339-0
   PubMed Web of Science ®Google Scholar
• Faria RX, Reis RA, Ferreira LG, et al. P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes. J Bioenerg Biomembr. 2016;48:309–324. doi:10.1007/s10863-016-9649-9
   PubMed Web of Science ®Google Scholar
• Cao F, Hu LQ, Yao SR, et al. P2X7 receptor: a potential therapeutic target for autoimmune diseases. Autoimmun Rev. 2019;18:767–777. doi:10.1016/j.autrev.2019.06.009
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Jiang LH, Roger S, et al. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells. Methods Enzymol. 2019;629:115–150.
   PubMed Web of Science ®Google Scholar
• Feng L, Chen Y, Ding R, et al. P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite. J Neuroinflammation. 2015;12:190. doi:10.1186/s12974-015-0409-2
   PubMed Web of Science ®Google Scholar
• Jiang S, Zhang Y, Zheng JH, et al. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation. Pharmacol Res. 2017;117:82–93. doi:10.1016/j.phrs.2016.11.040
   PubMed Web of Science ®Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248–255. doi:10.1038/nm.3806
   PubMed Web of Science ®Google Scholar
• Coll RC, Hill JR, Day CJ, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556–559. doi:10.1038/s41589-019-0277-7
   PubMed Web of Science ®Google Scholar
• Zahid A, Li B, Kombe AJK, et al. Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol. 2019;10:2538. doi:10.3389/fimmu.2019.02538
   PubMed Web of Science ®Google Scholar